.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Cantor Fitzgerald
Medtronic
Dow
Healthtrust
Express Scripts
Teva
Mallinckrodt
Daiichi Sankyo
Chinese Patent Office

Generated: December 16, 2017

DrugPatentWatch Database Preview

CARTIA XT Drug Profile

« Back to Dashboard

When do Cartia Xt patents expire, and when can generic versions of Cartia Xt launch?

Cartia Xt is a drug marketed by Actavis Labs Fl Inc and is included in one NDA.

The generic ingredient in CARTIA XT is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Drug patent expirations by year for CARTIA XT

Pharmacology for CARTIA XT

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl IncCARTIA XTdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL074752-002Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncCARTIA XTdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL074752-004Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncCARTIA XTdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL074752-001Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncCARTIA XTdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL074752-003Jul 9, 1998AB3RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Healthtrust
Baxter
Moodys
Federal Trade Commission
Cerilliant
Covington
QuintilesIMS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot